Grundium
Grundium Oy is a Finnish medical technology company that develops the Ocus line of compact digital pathology slide scanners and, following its May 2026 Visiopharm acquisition, an integrated AI-powered precision pathology platform serving diagnostic laboratories, biopharma research, academic institutions, and veterinary clinics across 40+ countries.
- Company typePrivate
- Founded2015
- HeadquartersTampere, Finland
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Grundium does
Grundium Oy is a Finnish medical technology company founded in 2015 in Tampere by former Nokia engineers, specializing in compact digital pathology microscope slide scanners marketed under the Ocus brand. The product line comprises the Ocus 20 (high-speed 20x scanning for intraoperative frozen sections), Ocus 40 (high-resolution 40x imaging for cytology and research), and the Ocus M Series (four-slide capacity for higher-volume labs). All scanners deliver browser-based access without additional software, support DICOM and SMB/HTTP export, and integrate with cloud platform services for remote consultation and telepathology workflows. The Ocus devices are CE-marked under the EU In Vitro Diagnostic Regulation (IVDR, EU 2017/746) for clinical/diagnostic use in Europe, while remaining classified as Research Use Only (RUO) in the United States.
In May 2026, Grundium acquired Denmark-based Visiopharm A/S, adding nine IVDR-cleared AI diagnostic algorithms and over 750 customer accounts across more than 40 countries, transforming the company from a hardware scanner vendor into an integrated precision pathology platform combining imaging hardware with AI-powered image analysis. The combined business serves diagnostic laboratories and hospitals, biopharmaceutical research and development organizations, academic and research institutions, and — through partnerships with Zoetis and Techcyte — the veterinary pathology vertical. Revenue mechanics mix one-time hardware sales of Ocus scanners with recurring cloud platform subscriptions and, post-Visiopharm, enterprise AI software subscriptions. Distribution combines direct enterprise field sales with a global distributor network including Fisher Healthcare (exclusive US distributor) and partners in Brazil, Turkey, Korea, India, Poland, and Greece. The company is privately held and backed by EW Healthcare Partners, a specialized healthcare investment firm.
Grundium firmographics
Firmographics- Name
- Grundium
- Legal name
- Grundium Oy
- Website
- https://grundium.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Grundium Oy is a Finnish medical technology company that develops the Ocus line of compact digital pathology slide scanners and, following its May 2026 Visiopharm acquisition, an integrated AI-powered precision pathology platform serving diagnostic laboratories, biopharma research, academic institutions, and veterinary clinics across 40+ countries.
- Ownership category
- akta.pro rank
Grundium industry classification
Industry- Product category
- Digital Pathology Imaging Systems
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB)
- akta.pro secondary industries
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Medical Imaging AI (HDAAAEAH)
Keywords
Where Grundium is headquartered
LocationHeadquarters
- HQ city
- Tampere
- HQ country
- Finland
- HQ region
- Europe
Offices2 records
Markets served
Grundium business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Hardware Sales - Ocus Scanners: Sale of physical microscope slide scanner devices including Ocus 20, Ocus 40, and Ocus M Series. One-time capital purchase model for laboratory and clinical equipment.
- Cloud Platform & Software Subscriptions: Ongoing cloud connectivity and software platform services for scanner management, remote access, data storage, and team collaboration through grundium.net cloud infrastructure.
- Enterprise Platform Solutions (Post-Visiopharm): Integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications for diagnostic laboratories, biopharmaceutical development, and research organizations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise sales - no public pricing available |
Go-to-market motion2 records
Distribution channels8 records
Marketing channels8 records
Grundium product offering
Product offeringCore offering
Grundium designs, manufactures, and sells the Ocus line of compact digital pathology microscope slide scanners (Ocus 20, Ocus 40, Ocus M Series) that convert glass slides into high-resolution whole-slide images accessible through any web browser. The company complements the hardware with a cloud platform for remote collaboration and, following the May 2026 acquisition of Visiopharm, AI-powered precision pathology image analysis software with nine IVDR-cleared diagnostic algorithms.
Product overview
Grundium offers the Ocus line of compact digital pathology microscope slide scanners, consisting of three scanner models: Ocus 20 (high-speed 20x scanning for frozen sections and routine histology), Ocus 40 (high-resolution 40x scanning for detailed cytology and research), and Ocus M Series (four-slide capacity multi-slide scanner for high-throughput labs). The scanners feature browser-based interfaces, onboard processing, and cloud connectivity through Grundium Cloud for remote access and collaboration. The product line recently expanded through the acquisition of Visiopharm, adding AI-powered precision pathology software with nine IVDR-cleared diagnostic algorithms for automated image analysis, creating an integrated end-to-end platform combining digital slide scanning with AI-powered diagnostic applications for diagnostic laboratories, biopharmaceutical research, and clinical applications.
Differentiator
Problem solved
Functional benefit
Brands
- Ocus®: Ocus® is Grundium's product line of microscope slide scanners for digital pathology, including Ocus® 20, Ocus® 40, and Ocus® M series models.
- Ocus® 20
- Ocus® 40
- Ocus® M Series
Products and services
- Ocus 20 High-speed digital microscope slide scanner optimized for 20x magnification, intended for time-sensitive procedures such as intraoperative frozen sections and routine histology where rapid, reliable scanning is critical.
- Ocus 40 High-resolution digital microscope slide scanner at 40x magnification delivering exceptional clarity for cytology and other disciplines demanding precise image quality and detailed specimen examination.
- Ocus M Series Multi-slide digital microscope scanner with four-slide capacity and innovative slide tray for extended scanning sessions. Supports both 20x and 40x magnification, designed for high-performance labs requiring reliable multi-slide scanning with minimal hands-on time.
- Visiopharm AI Software AI-driven precision pathology software providing nine IVDR-cleared diagnostic algorithms for automated image analysis, supporting cancer detection, tissue quantification, and biomarker analysis for diagnostic laboratories, biopharmaceutical research, and clinical applications.
Quantifiable outcome
- Reduced diagnostic turnaround time from days/weeks to minutes in veterinary telepathology applications
- +3 more outcomes
Companies that use Grundium
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Grundium technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability4 records
Feature11 records
Grundium partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, primary and notable.
- VisiopharmcoreGrundium acquired Denmark-based Visiopharm, an AI-driven precision pathology software provider, to create an integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications. Visiopharm brings nine IVDR-cleared diagnostic algorithms and over 750 customer accounts. The acquisition builds on a pre-existing partnership between the two firms.
- Fisher HealthcareprimaryExclusive distributor for Grundium Ocus scanners in the United States, operating under Fisher Scientific brand. Manages local sales, customer relationships, and support for American customers.
- Biolab BrazilprimaryLocal distributor partner for Brazil market, providing sales and customer support services for Brazilian laboratories and healthcare institutions.
- Neogen DiagnostikprimaryLocal distributor partner for Turkey (Türkiye), with sales office in Istanbul providing regional sales and support for Turkish customers.
- SeongkohnprimaryLocal distributor partner for South Korea market, managing sales and customer support for Korean customers.
- Sentier IndiaprimaryLocal distributor partner for India market, operating as Sentier Healthcare, providing sales and support services for Indian customers.
- MarfourprimaryLocal distributor partner for Poland market, providing regional sales and customer support services.
- BioanalyticaprimaryLocal distributor partner for Greece market, managing sales and customer support for Greek customers.
- Washington University in St. LouisnotableImplemented Grundium Ocus scanners for digital pathology workflows to improve rapid on-site evaluations (ROSE) and frozen section reviews. The partnership demonstrates application in major academic hospital settings with multi-location deployment.
- Zoetis (VetScan Imagyst)notableZoetis integrated Grundium Ocus®40 scanners into their VetScan Imagyst telepathology platform for veterinary diagnostics. Zoetis provides the Ocus scanners to independent clinics for AI-powered parasite detection and cytology reviews via remote pathologists.
- TechcytenotableTechnology partner providing AI-powered digital diagnostic testing for Zoetis VetScan Imagyst platform. Techcyte's deep-learning AI algorithms analyze scanned images for automated parasite detection in veterinary samples.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Grundium competitors and assessment
Company assessmentDirect peers
- Hamamatsu Photonics: Hamamatsu's NanoZoomer series is the most widely deployed whole slide imaging scanner globally. Directly comparable to Grundium's Ocus line in target customer (pathology labs) and product category (microscope slide digitization), with broader installed base and FDA-cleared clinical use in the US.
- 3DHISTECH: Hungarian vendor of PANNORAMIC whole slide scanners and digital pathology software. Directly comparable compact and high-throughput scanners serving similar clinical and research pathology customers across Europe and globally.
- Huron Digital Pathology: Canadian maker of TissueScope whole slide scanners for clinical and research pathology. Closely comparable product positioning to Grundium's Ocus line, with similar emphasis on high-resolution imaging and remote workflows.
- Motic (Motic Digital Pathology): Motic's EasyScan and VM series compete with Grundium in affordable, compact WSI for clinical and educational pathology labs. Strong presence in Asia-Pacific and overlaps on price-sensitive mid-market segments.
- OptraSCAN: US-based digital pathology vendor offering affordable WSI scanners and a cloud platform. Closely comparable to Grundium on positioning toward accessible, mid-market pathology digitization rather than enterprise tier-one deployments.
- Indica Labs: Indica Labs' HALO software platform is the closest direct competitor to Visiopharm's AI image analysis suite and now overlaps with Grundium's combined platform post-acquisition. Both target biopharma research and clinical pathology AI quantification workflows.
Broad incumbents
- Leica Biosystems (Danaher): Leica's Aperio GT 450 and AT2 scanners are entrenched enterprise WSI platforms integrated into Leica's broader histopathology portfolio (tissue processors, stains, microscopes). Competes with Grundium in mid-to-large hospital labs with bundled solutions and global service footprint.
- Roche (Ventana): Roche's digital pathology portfolio (Ventana DP200, navify Digital Pathology) competes with Grundium via integrated companion-diagnostic workflows. As a global diagnostics incumbent, Roche has unmatched enterprise sales reach and pulls WSI into companion diagnostic deals.
- Philips (IntelliSite): Philips IntelliSite Pathology Solution is an FDA-cleared WSI platform often paired with Philips PACS and clinical informatics. Competes with Grundium in large hospital networks seeking single-vendor enterprise imaging strategies.
Emerging players
- PathAI: PathAI focuses on AI-powered pathology diagnostics and biopharma partnerships with proprietary algorithms. Partially overlaps with Visiopharm (now part of Grundium) in computational pathology AI for cancer detection and biomarker quantification.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Grundium social profiles
Digital presenceGrundium compliance and trust
Trust signalCompliance3 records
Grundium financial estimates
Financial estimateRevenue estimate
Valuation estimate
Grundium leadership team
Management profileNumber of profiles
Profiles4 records
Grundium subsidiaries and ownership
Company hierarchySubsidiaries2 records
Grundium funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Grundium M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Grundium
What does Grundium do?
Grundium designs, manufactures, and sells the Ocus line of compact digital pathology microscope slide scanners (Ocus 20, Ocus 40, Ocus M Series) that convert glass slides into high-resolution whole-slide images accessible through any web browser. The company complements the hardware with a cloud platform for remote collaboration and, following the May 2026 acquisition of Visiopharm, AI-powered precision pathology image analysis software with nine IVDR-cleared diagnostic algorithms.
Is Grundium a public or private company?
Grundium is a private company. It is classified as venture growth investor backed and is currently operating.
When was Grundium founded?
Grundium was founded in 2015. It employs 51 to 100 people.
Where is Grundium based?
Grundium is headquartered in Tampere, Finland, in the Europe region.
How does Grundium make money?
Three revenue lines are on record. Hardware Sales - Ocus Scanners are the primary driver. The others are cloud Platform & Software Subscriptions and enterprise Platform Solutions (Post-Visiopharm).
Who are Grundium's main competitors?
Direct peers on record are Hamamatsu Photonics, 3DHISTECH, Huron Digital Pathology, Motic (Motic Digital Pathology), OptraSCAN and Indica Labs. Broad incumbents are Leica Biosystems (Danaher), Roche (Ventana) and Philips (IntelliSite). PathAI is listed as an emerging player.
Does Grundium have an API?
No public API is recorded for Grundium.
What industry is Grundium in?
Grundium's product category is Digital Pathology Imaging Systems. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3841.